BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Business

  Apollo Medical Holdings Reports Its Fiscal Year 2017 Financial Results

  Apollo Medical Holdings, Inc. announced its fiscal year financial results for the year ended December 31, 2017.

  April 2, 2018

   · 

  3 min read
• Business

  GeneNews to Report Fourth Quarter and Full Year 2017 Financial Results on April 3, 2018 - Conference Call to Follow

  GeneNews Limited announced that it will release its Fourth Quarter and Full Year 2017 financial results before markets open on Tuesday, April 3, 2017.

  April 2, 2018

   · 

  1 min read
• Biotech Beach

  AVITA Medical Announces Schedule for Six RECELL® Device Presentations at American Burn Association (ABA) 50th Annual Meeting

  Avita Medical announced new data to be presented describing clinical and cost-savings advantages of RECELL® Device in the treatment of severe burns at the American Burn Association (ABA) 50th Annual Meeting to be held from April 10 through 13, 2018 at the Hyatt Regency Chicago in Chicago.

  April 2, 2018

   · 

  5 min read
• Deals

  BioCryst Pharmaceuticals Files Definitive Proxy Statement in Connection with Pending Merger with Idera Pharmaceuticals

  BioCryst Mails Letter to Stockholders Highlighting Compelling Upside Opportunity

  April 2, 2018

   · 

  15 min read
• FDA

  FDA Approves First Therapy for Patients with MRD-Positive ALL

  This new indication marks the first time the FDA has approved a therapy based on MRD status.

  April 2, 2018

   · 

  3 min read
• Biotech Bay

  ReShape Lifesciences Announces $6 Million Registered Direct Offering

  ReShape has entered into a securities purchase agreement with an institutional investor providing for the purchase and sale in a registered direct offering of shares of series D convertible preferred stock and a warrant to purchase shares of common stock for a purchase price of $6.0 million.

  April 2, 2018

   · 

  6 min read
• Business

  Allied Patients, Inc. Launches to Manufacture Affordable Generic Alternatives

  Physician creates pharmaceutical startup to challenge outdated pricing and distribution practices that keep medications out of reach for his patients.

  April 2, 2018

   · 

  2 min read
• Business

  Praxair Announces First Quarter 2018 Earnings and Conference Call Schedule

  Praxair, Inc. (NYSE:PX) will release its first quarter 2018 financial results on Thursday, April 26, 2018, before the market opens and will webcast its conference call at 11:00 a.m. ET that morning.

  April 2, 2018

   · 

  1 min read
• Policy

  IVC Filter Lawsuit News: C.R. Bard Ordered to Pay $3.6 Million at Conclusion of First Federal Bellwether Trial, Bernstein Liebhard LLP Reports

  C.R. Bard, Inc. has been ordered to pay $3.6 million to a Georgia woman who suffered serious complications after the company’s G2 inferior vena cava (IVC) filter fractured inside her body

  April 2, 2018

   · 

  3 min read
• Biotech Beach

  Edison International Awards 30 High School Seniors $1.2 Million in Scholarships

  Edison International, the parent company of Southern California Edison, has announced the names of 30 high school seniors awarded $1.2 million in scholarships to support their dreams to make a difference in the world through the study of science, technology, engineering or math — known as STEM.

  April 2, 2018

   · 

  2 min read